SCHEMBL29930774

SCHEMBL29930774

C[Si](C)(C)CCOCn1ncc2cc(-c3cc(F)ccc3F)cnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.41
ALOX5AP P20292 4/20 0.38
FEN1 P39748 4/20 0.38
GRIN2B Q13224 4/20 0.37
S1PR1 P21453 3/20 0.36
F2RL1 P55085 1/20 0.36
GRIN1 Q05586 3/20 0.34
ABL1 P00519 2/20 0.34
GAK O14976 1/20 0.34
EPHA1 P21709 1/20 0.34
EPHA2 P29317 1/20 0.34
EPHA3 P29320 1/20 0.34
EPHB2 P29323 1/20 0.34
MAPK8 P45983 1/20 0.34
EPHB3 P54753 1/20 0.34
EPHB4 P54760 1/20 0.34
EPHB1 P54762 1/20 0.34
EPHA4 P54764 1/20 0.34
SIK1 P57059 1/20 0.34
SIK2 Q9H0K1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930600 0.79 HDAC8 (0.36) DGAT1ALOX5APFEN1F2RL1BRD4
SCHEMBL29930403 0.78 FTO (0.39) DGAT1ALOX5APFEN1GRIN2BGRIN1
SCHEMBL16536822 0.78 F2RL1 (0.35) DGAT1ALOX5APFEN1GRIN2BF2RL1
SCHEMBL29930814 0.78 PDGFRB (0.41) DGAT1GAK
SCHEMBL31469272 0.78 DGAT1 (0.35) DGAT1ALOX5APFEN1BRD4CREBBP
SCHEMBL29930423 0.77 MAP4K4 (0.40) DGAT1ALOX5APFEN1BRD4CREBBP
SCHEMBL1565921 0.76 DGAT1 (0.40) DGAT1F2RL1
SCHEMBL29705469 0.76 DGAT1 (0.33) DGAT1F2RL1
SCHEMBL18188139 0.76 DGAT1 (0.33) DGAT1ALOX5APFEN1F2RL1
SCHEMBL19023260 0.76 DGAT1 (0.33) DGAT1F2RL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed